The case for simplifying and using absolute targets for viral hepatitis elimination goals
© 2020 John Wiley & Sons Ltd..
The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targets for the care and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These announcements and targets were important in raising awareness and calling for action; however, tracking countries' progress towards these elimination goals has provided insights to the limitations of these targets. The existing targets compare a country's progress relative to its 2015 values, penalizing countries who started their programmes prior to 2015, countries with a young population, or countries with a low prevalence. We recommend that (1) WHO simplify the hepatitis elimination targets, (2) change to absolute targets and (3) allow countries to achieve these disease targets with their own service coverage initiatives that will have the maximum impact. The recommended targets are as follows: reduce HCV new chronic cases to ≤5 per 100 000, reduce HBV prevalence among 1-year-olds to ≤0.1%, reduce HBV and HCV mortality to ≤5 per 100 000, and demonstrate HBV and HCV year-to-year decrease in new HCV- and HBV-related HCC cases. The objective of our recommendations is not to lower expectations or diminish the hepatitis elimination standards, but to provide clearer targets that recognize the past and current elimination efforts by countries, help measure progress towards true elimination, and motivate other countries to follow suit.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Journal of viral hepatitis - 28(2021), 1 vom: 01. Jan., Seite 12-19 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Polaris Observatory Collaborators [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 31.08.2021 Date Revised 31.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jvh.13412 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315506059 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315506059 | ||
| 003 | DE-627 | ||
| 005 | 20231225155050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jvh.13412 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315506059 | ||
| 035 | |a (NLM)32979881 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Polaris Observatory Collaborators |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The case for simplifying and using absolute targets for viral hepatitis elimination goals |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2021 | ||
| 500 | |a Date Revised 31.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 John Wiley & Sons Ltd. | ||
| 520 | |a The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targets for the care and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These announcements and targets were important in raising awareness and calling for action; however, tracking countries' progress towards these elimination goals has provided insights to the limitations of these targets. The existing targets compare a country's progress relative to its 2015 values, penalizing countries who started their programmes prior to 2015, countries with a young population, or countries with a low prevalence. We recommend that (1) WHO simplify the hepatitis elimination targets, (2) change to absolute targets and (3) allow countries to achieve these disease targets with their own service coverage initiatives that will have the maximum impact. The recommended targets are as follows: reduce HCV new chronic cases to ≤5 per 100 000, reduce HBV prevalence among 1-year-olds to ≤0.1%, reduce HBV and HCV mortality to ≤5 per 100 000, and demonstrate HBV and HCV year-to-year decrease in new HCV- and HBV-related HCC cases. The objective of our recommendations is not to lower expectations or diminish the hepatitis elimination standards, but to provide clearer targets that recognize the past and current elimination efforts by countries, help measure progress towards true elimination, and motivate other countries to follow suit | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Razavi, Homie |e investigator |4 oth | |
| 700 | 1 | |a Blach, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Razavi-Shearer, Devin |e investigator |4 oth | |
| 700 | 1 | |a Abaalkhail, Faisal |e investigator |4 oth | |
| 700 | 1 | |a Abbas, Zaigham |e investigator |4 oth | |
| 700 | 1 | |a Abdallah, Ayat |e investigator |4 oth | |
| 700 | 1 | |a Abrao Ferreira, Paulo |e investigator |4 oth | |
| 700 | 1 | |a Abu Raddad, Laith Jamal |e investigator |4 oth | |
| 700 | 1 | |a Adda, Danjuma |e investigator |4 oth | |
| 700 | 1 | |a Agarwal, Kosh |e investigator |4 oth | |
| 700 | 1 | |a Aghemo, Alessio |e investigator |4 oth | |
| 700 | 1 | |a Ahmed, Aijaz |e investigator |4 oth | |
| 700 | 1 | |a Al-Busafi, Said A |e investigator |4 oth | |
| 700 | 1 | |a Al-Hamoudi, Waleed |e investigator |4 oth | |
| 700 | 1 | |a Al-Kaabi, Saad |e investigator |4 oth | |
| 700 | 1 | |a Al-Romaihi, Hamad |e investigator |4 oth | |
| 700 | 1 | |a Aljarallah, Badr |e investigator |4 oth | |
| 700 | 1 | |a AlNaamani, Khalid |e investigator |4 oth | |
| 700 | 1 | |a Alqahtani, Saleh |e investigator |4 oth | |
| 700 | 1 | |a Alswat, Khalid |e investigator |4 oth | |
| 700 | 1 | |a Altraif, Ibrahim |e investigator |4 oth | |
| 700 | 1 | |a Asselah, Tarik |e investigator |4 oth | |
| 700 | 1 | |a Bacon, Bruce |e investigator |4 oth | |
| 700 | 1 | |a Bessone, Fernando |e investigator |4 oth | |
| 700 | 1 | |a Bizri, Abdul Rahman |e investigator |4 oth | |
| 700 | 1 | |a Block, Tim |e investigator |4 oth | |
| 700 | 1 | |a Bonino, Ferruccio |e investigator |4 oth | |
| 700 | 1 | |a Brandão-Mello, Carlos Eduardo |e investigator |4 oth | |
| 700 | 1 | |a Brown, Kimberly |e investigator |4 oth | |
| 700 | 1 | |a Bruggmann, Philip |e investigator |4 oth | |
| 700 | 1 | |a Brunetto, Maurizia Rossana |e investigator |4 oth | |
| 700 | 1 | |a Buti, Maria |e investigator |4 oth | |
| 700 | 1 | |a Cabezas, Joaquín |e investigator |4 oth | |
| 700 | 1 | |a Calleja, Jose Luis |e investigator |4 oth | |
| 700 | 1 | |a Castro Batänjer, Erika |e investigator |4 oth | |
| 700 | 1 | |a Chan, Henry Lik-Yuen |e investigator |4 oth | |
| 700 | 1 | |a Chang, Henry |e investigator |4 oth | |
| 700 | 1 | |a Chen, Chien-Jen |e investigator |4 oth | |
| 700 | 1 | |a Christensen, Peer Brehm |e investigator |4 oth | |
| 700 | 1 | |a Chuang, Wan-Long |e investigator |4 oth | |
| 700 | 1 | |a Cisneros, Laura |e investigator |4 oth | |
| 700 | 1 | |a Cohen, Chari |e investigator |4 oth | |
| 700 | 1 | |a Colombo, Massimo |e investigator |4 oth | |
| 700 | 1 | |a Conway, Brian |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Curtis |e investigator |4 oth | |
| 700 | 1 | |a Craxi, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Crespo, Javier |e investigator |4 oth | |
| 700 | 1 | |a Croes, Esther |e investigator |4 oth | |
| 700 | 1 | |a Cryer, Donna |e investigator |4 oth | |
| 700 | 1 | |a Cupertino de Barros, Fernando Passos |e investigator |4 oth | |
| 700 | 1 | |a Derbala, Moutaz |e investigator |4 oth | |
| 700 | 1 | |a Dillon, John |e investigator |4 oth | |
| 700 | 1 | |a Doss, Wahid |e investigator |4 oth | |
| 700 | 1 | |a Dou, Xiaoguang |e investigator |4 oth | |
| 700 | 1 | |a Doyle, Joseph |e investigator |4 oth | |
| 700 | 1 | |a Duberg, Ann-Sofi |e investigator |4 oth | |
| 700 | 1 | |a Dugan, Ellen |e investigator |4 oth | |
| 700 | 1 | |a Dunn, Rick |e investigator |4 oth | |
| 700 | 1 | |a Dusheiko, Geoffrey |e investigator |4 oth | |
| 700 | 1 | |a El Khayat, Hisham |e investigator |4 oth | |
| 700 | 1 | |a El-Sayed, Manal H |e investigator |4 oth | |
| 700 | 1 | |a Eshraghian, Ahad |e investigator |4 oth | |
| 700 | 1 | |a Esmat, Gamal |e investigator |4 oth | |
| 700 | 1 | |a Esteban Mur, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Ezzat, Sameera |e investigator |4 oth | |
| 700 | 1 | |a Falconer, Karolin |e investigator |4 oth | |
| 700 | 1 | |a Fassio, Eduardo |e investigator |4 oth | |
| 700 | 1 | |a Ferrinho, Paulo |e investigator |4 oth | |
| 700 | 1 | |a Flamm, Steven |e investigator |4 oth | |
| 700 | 1 | |a Flisiak, Robert |e investigator |4 oth | |
| 700 | 1 | |a Foster, Graham |e investigator |4 oth | |
| 700 | 1 | |a Fung, James |e investigator |4 oth | |
| 700 | 1 | |a García-Samaniego, Javier |e investigator |4 oth | |
| 700 | 1 | |a Gish, Robert G |e investigator |4 oth | |
| 700 | 1 | |a Gonçales, Fernando |e investigator |4 oth | |
| 700 | 1 | |a Halota, Waldemar |e investigator |4 oth | |
| 700 | 1 | |a Hamoudi, Waseem |e investigator |4 oth | |
| 700 | 1 | |a Hassany, Mohamed |e investigator |4 oth | |
| 700 | 1 | |a Hatzakis, Angelos |e investigator |4 oth | |
| 700 | 1 | |a Hay, Susan |e investigator |4 oth | |
| 700 | 1 | |a Himatt, Sayed |e investigator |4 oth | |
| 700 | 1 | |a Hoepelman, I M |e investigator |4 oth | |
| 700 | 1 | |a Hsu, Yao-Chun |e investigator |4 oth | |
| 700 | 1 | |a Hui, Yee Tak |e investigator |4 oth | |
| 700 | 1 | |a Hunyady, Bela |e investigator |4 oth | |
| 700 | 1 | |a Jacobson, Ira |e investigator |4 oth | |
| 700 | 1 | |a Janjua, Naveed |e investigator |4 oth | |
| 700 | 1 | |a Janssen, Harry |e investigator |4 oth | |
| 700 | 1 | |a Jarcuska, Peter |e investigator |4 oth | |
| 700 | 1 | |a Kabagambe, Kenneth |e investigator |4 oth | |
| 700 | 1 | |a Kanto, Tatsuya |e investigator |4 oth | |
| 700 | 1 | |a Kao, Jia-Horng |e investigator |4 oth | |
| 700 | 1 | |a Kaymakoglu, Sabahattin |e investigator |4 oth | |
| 700 | 1 | |a Kershenobich, David |e investigator |4 oth | |
| 700 | 1 | |a Khamis, Faryal |e investigator |4 oth | |
| 700 | 1 | |a Kim, Dong Joon |e investigator |4 oth | |
| 700 | 1 | |a Kim, Do Young |e investigator |4 oth | |
| 700 | 1 | |a Kondili, Loreta A |e investigator |4 oth | |
| 700 | 1 | |a Kottilil, Shyamasundaran |e investigator |4 oth | |
| 700 | 1 | |a Kramvis, Anna |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of viral hepatitis |d 1997 |g 28(2021), 1 vom: 01. Jan., Seite 12-19 |w (DE-627)NLM074659642 |x 1365-2893 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:12-19 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jvh.13412 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2021 |e 1 |b 01 |c 01 |h 12-19 | ||